Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer (MODULATE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03009058
Recruitment Status : Terminated (Commercial reasons)
First Posted : January 4, 2017
Last Update Posted : August 9, 2018
Information provided by (Responsible Party):
Immodulon Therapeutics Ltd

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 30, 2017
Actual Study Completion Date : August 30, 2017